Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $12.93 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.